These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30471388)

  • 1. Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling.
    Venkatraghavan V; Bron EE; Niessen WJ; Klein S;
    Neuroimage; 2019 Feb; 186():518-532. PubMed ID: 30471388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease.
    Archetti D; Ingala S; Venkatraghavan V; Wottschel V; Young AL; Bellio M; Bron EE; Klein S; Barkhof F; Alexander DC; Oxtoby NP; Frisoni GB; Redolfi A; ;
    Neuroimage Clin; 2019; 24():101954. PubMed ID: 31362149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing the effect of APOE on Alzheimer's disease progression using an event-based model for stratified populations.
    Venkatraghavan V; Klein S; Fani L; Ham LS; Vrooman H; Ikram MK; Niessen WJ; Bron EE;
    Neuroimage; 2021 Feb; 227():117646. PubMed ID: 33338617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression along data-driven disease timelines is predictive of Alzheimer's disease in a population-based cohort.
    Venkatraghavan V; Vinke EJ; Bron EE; Niessen WJ; Ikram MA; Klein S; Vernooij MW;
    Neuroimage; 2021 Sep; 238():118233. PubMed ID: 34091030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. sEBM: Scaling Event Based Models to Predict Disease Progression via Implicit Biomarker Selection and Clustering.
    Tandon R; Kirkpatrick A; Mitchell CS
    Inf Process Med Imaging; 2023 Jun; 13939():208-221. PubMed ID: 38680427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohort.
    Jedynak BM; Lang A; Liu B; Katz E; Zhang Y; Wyman BT; Raunig D; Jedynak CP; Caffo B; Prince JL;
    Neuroimage; 2012 Nov; 63(3):1478-86. PubMed ID: 22885136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression modelling of Alzheimer's disease using probabilistic principal components analysis.
    Saint-Jalmes M; Fedyashov V; Beck D; Baldwin T; Faux NG; Bourgeat P; Fripp J; Masters CL; Goudey B;
    Neuroimage; 2023 Sep; 278():120279. PubMed ID: 37454702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
    Wang HF; Tan L; Cao L; Zhu XC; Jiang T; Tan MS; Liu Y; Wang C; Tsai RM; Jia JP; Yu JT;
    J Alzheimers Dis; 2016; 51(1):227-36. PubMed ID: 26836176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disease state fingerprint for evaluation of Alzheimer's disease.
    Mattila J; Koikkalainen J; Virkki A; Simonsen A; van Gils M; Waldemar G; Soininen H; Lötjönen J;
    J Alzheimers Dis; 2011; 27(1):163-76. PubMed ID: 21799247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simulation system for biomarker evolution in neurodegenerative disease.
    Young AL; Oxtoby NP; Ourselin S; Schott JM; Alexander DC;
    Med Image Anal; 2015 Dec; 26(1):47-56. PubMed ID: 26356148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.
    Ye T; Zu C; Jie B; Shen D; Zhang D;
    Brain Imaging Behav; 2016 Sep; 10(3):739-49. PubMed ID: 26311394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilistic disease progression modeling to characterize diagnostic uncertainty: Application to staging and prediction in Alzheimer's disease.
    Lorenzi M; Filippone M; Frisoni GB; Alexander DC; Ourselin S;
    Neuroimage; 2019 Apr; 190():56-68. PubMed ID: 29079521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computational method for computing an Alzheimer's disease progression score; experiments and validation with the ADNI data set.
    Jedynak BM; Liu B; Lang A; Gel Y; Prince JL;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S178-84. PubMed ID: 25444605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease.
    Demirtaş M; Falcon C; Tucholka A; Gispert JD; Molinuevo JL; Deco G
    Neuroimage Clin; 2017; 16():343-354. PubMed ID: 28861336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.
    Llano DA; Bundela S; Mudar RA; Devanarayan V;
    PLoS One; 2017; 12(8):e0182098. PubMed ID: 28771542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal clinical score prediction in Alzheimer's disease with soft-split sparse regression based random forest.
    Huang L; Jin Y; Gao Y; Thung KH; Shen D;
    Neurobiol Aging; 2016 Oct; 46():180-91. PubMed ID: 27500865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
    Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB
    J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.
    Schmidt-Richberg A; Ledig C; Guerrero R; Molina-Abril H; Frangi A; Rueckert D;
    PLoS One; 2016; 11(4):e0153040. PubMed ID: 27096739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instantiated mixed effects modeling of Alzheimer's disease markers.
    Guerrero R; Schmidt-Richberg A; Ledig C; Tong T; Wolz R; Rueckert D;
    Neuroimage; 2016 Nov; 142():113-125. PubMed ID: 27381077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.